RFP - supply of diabetes agents: SGLT-2 inhibitors, GLP-1 agonists and DPP-4 inhibitors – ADDENDUM ADDED TO EXTEND SOLE SUPPLY PERIOD

Medicines

RFP Closed

PHARMAC invites proposals for the supply of diabetes agents: SGLT-2 inhibitors, GLP-1 agonists and DPP-4 inhibitors in New Zealand.

This request for proposals (RFP) document incorporates the following schedules:

Full text of RFP - supply of diabetes agents [PDF, 275 KB]

Addendum - extension to sole supply period [PDF, 46 KB]

PHARMAC's standard terms and conditions [PDF, 79 KB]

[PDF, 79 KB]For important information regarding a change in RFP requirements please read the addendum, '2020-02-13 ADDENDUM - EXTENSION TO SOLE SUPPLY PERIOD' above.

If you wish to submit a proposal, you must submit it to PHARMAC via the Government Electronic Tenders Service (GETS) (www.gets.govt.nz(external link)) no later than 4pm NZT Monday 16 March 2020 - RFx ID 22162611.

PHARMAC will be holding a supplier briefing and Q&A on Monday 3 February 2020 in Auckland to provide information about the types of proposals sought through this RFP. Full details to be confirmed and will be published on GETS. Please contact procurement@pharmac.govt.nz if you would like to attend.

We encourage suppliers to register with GETS and subscribe to this RFP. If you have any questions about this RFP, please post these on GETS (www.gets.govt.nz(external link)). 

We look forward to receiving your proposals.